imidocarb

Known as: Imidocarb [Chemical/Ingredient], Urea, N,N'-bis(3-(4,5-dihydro-1H-imidazol-2-yl)phenyl)- 
One of ANTIPROTOZOAL AGENTS used especially against BABESIA in livestock. Toxicity has been reported.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1969-2018
051019692018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Canine babesiosis caused by different Babesia species is a protozoal tick-borne disease with worldwide distribution and global… (More)
Is this relevant?
2011
2011
BACKGROUND Imidocarb or a combination of atovaquone and azithromycin (A&A) has been suggested for treatment of cats with… (More)
Is this relevant?
2006
2006
The recommended treatment for canine ehrlichiosis is tetracycline or its analog doxycycline, although recent reports have… (More)
Is this relevant?
2003
2003
The therapeutic efficacy of imidocarb, artesunate, arteether, buparvaquone and arteether+buparvaquone combination was evaluated… (More)
Is this relevant?
2003
2003
It is proposed that the chronic asymptomatic carrier state produced by Babesia canis infection could make dogs more resistant… (More)
Is this relevant?
1996
1996
Imidocarb dipropionate, formulated as Imizol, is used for the treatment and prophylaxis of bovine babesiosis. Several studies… (More)
Is this relevant?
1995
1995
Imidocarb residues in liver and muscle were measured by HPLC after a single therapeutic dose to cattle (3 mg imidocarb… (More)
Is this relevant?
1987
1987
The therapeutic efficacies of imidocarb and parvaquone were tested against Babesia equi of European origin in carrier horses and… (More)
Is this relevant?
1984
1984
One of 13 healthy dogs used in a pharmacokinetic study of imidocarb dipropionate died due to difficulty in breathing, tachycardia… (More)
  • figure I
  • figure 2
Is this relevant?
1981
1981
Eight dogs, given imidocarb dipropionate subcutaneously at a dose of 6 mg/kg, were challenged with a sporozoite stabilate of a… (More)
Is this relevant?